Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New eye pressure gadget put to the test

NCT ID NCT06748092

Diagnosis Sponsor: Icare Finland Oy Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study checked if a new device called the iCare IC1000 can accurately measure pressure inside the eye. Researchers compared it to standard tonometers in 168 adults. The goal was to see if the IC1000 meets official accuracy standards for use in clinics.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could confirm that the iCare IC1000 is a reliable tool for measuring eye pressure, potentially improving glaucoma screening and monitoring.
What could go wrong
This is a small, completed validation study, not a treatment trial. It only checks accuracy, not whether using the device improves patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

168 people

The number who actually took part.

Started

Oct 2025

Finished

Mar 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years Exclusion Criteria: * Subjects with only one functional eye * Subjects having poor or eccentric fixation in the study eye * High corneal astigmatism \>3D in the study eye * Central corneal scarring * History of prior incisional glaucoma surgery or corneal surgery, including corneal refractive laser surgery in the study eye * Microphthalmos * Buphthalmos * Contact lens use within one week of continuous wear and within one hour if lens is worn occasionally * Dry eyes (clinically significant) * Lid squeezers - blepharospasm * Nystagmus * Keratoconus * Any other corneal or conjunctival pathology or infection relevant to this study * Central corneal thickness greater than 600 µm or less than 500 µm in the study eye * Cataract Extraction within last 2 months in the study eye

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intraocular pressure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ocular hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Intraocular pressure

Contacts and locations

Locations

  • Nova Scotia Health/Dalhousie University

    Halifax, Nova Scotia, B3H 2Y9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.